Health Conditions

Potassium sparing diuretics Nursing Implications and Drug Study

Potassium Sparing Diuretics

Potassium sparing diuretics Nursing Implications and Drug Study

POTASSIUM SPARING DIURETICS

GENERAL DESCRIPTION

Potassium sparing diuretics caused diuresis without loss of potassium unlike other diuretics. They are less potent diuretic agents therefore potassium sparing diuretics may combine with other diuretics to prevent the loss of potassium and further increase in diuretic effects.

EXAMPLE:

Potassium sparing diuretics are divided into two types according to their chemical structure and mechanism of action, as below

1) Competitive antagonists and structurally related to aldosterone: Spironolactone, Eplerenone

  1. Na+/K+ exchange antagonists that do not compete with aldosterone: Amiloride, Triamterene.

SPIRONOLACTONE

GENERIC NAME: Spironolactone

BRAND NAME: Aldactone

GENERAL DESCRIPTION

Spironolactone is a synthetic steroid that act as a competitive antagonist to aldosterone. It is also called potassium sparing diuretics because it prevents the loss of potassium from the body. Prolong use of spironolactone can cause in heart failure and its use is limited when there is hyperaldosteronism whether primary or secondary. Spironolactone is marketed as combination tablets with loop or thiazide diuretics as a means of avoiding hypokalemia.

MECHANISM OF ACTION

Spironolactone indirectly inhibit the Na+ reabsorption. The main site of action of Spironolactone is intercalated cells in cortical collecting duct. These cells have aldosterone receptors where aldosterone binds and make sodium-potassium pumps which goes to the cell membrane and reabsorb sodium and secrete potassium. But when spironolactone binds with these receptors then antagonize the aldosterone effects and thus inhibit Na+/ K+ pump. This action cause natriuresis with loss of water and prevent excretion of potassium. Only a small portion of Na+ is reabsorbed by this mechanism, spironolactone is not potent diuretic agents.

PHARMACOKINETICS

Spironolactone is given orally has less bioavailability, which can increase when taken with meal. Spironolactone has very slow onset of action. Spironolactone has high protein binding. It is metabolized by the liver when given orally. Spironolactone is a prodrug and its metabolites are active and longer half-life in comparison. Spironolactone is excreted by kidney.

INDICATIONS

CONTRAINDICATIONS

SIDE EFFECTS & ADVERSE EFFECTS

DRUG INTERACTION

NURSING CONSIDERATIONS AND IMPLICATIONS

PATIENT EDUCATION

AMILORIDE

GENERIC NAME: Amiloride

BRAND NAME: Midamor

GENERAL DESCRIPTION

Amiloride is a potassium sparing diuretic. Amiloride blocks the epithelial sodium channel thereby inhibits sodium reabsorption at this site and prevent loss of potassium thus called potassium sparing diuretics. Amiloride is marketed as combination tablets with loop or thiazide diuretics as a means of avoiding hypokalemia.

MECHANISM OF ACTION

Amiloride is direct inhibitors of Na+ influx in the late distal convoluted tubule and collecting duct in the renal nephron. It blocks the epithelial sodium channel and inhibits sodium reabsorption at this site and prevent loss of potassium which in result inhibits the exchange of sodium and potassium at the Na+/ K+ pump. Only a small portion of Na is reabsorbed by this mechanism, Amiloride is not potent diuretic agent.

PHARMACOKINETICS

Amiloride is given orally. It is metabolized in the liver but major route of elimination is renal excretion. Amiloride is longer half-life than Triamterene.  It is excreted un-metabolized in the urine and feces. Peak serum levels are seen at three hours, and the serum half-life is six hours.

INDICATIONS

CONTRAINDICATIONS

SIDE EFFECTS & ADVERSE EFFECTS

DRUG INTERACTION

NURSING IMPLICATIONS AND CONSIDERATIONS

PATIENT EDUCATION

 

Exit mobile version